ArticleOncotarget2020

First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients.

Natalia V Eremina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.